
“Promoter exodus meets DII lifeline in debt-free pharma shell.”
No clear market view today
The signals we track (volume, delivery, price trend, deals, breadth and flows) aren't aligned for BROOKStoday. That isn't bearish, just inconclusive.
MACD is above signal line with positive momentum
India-specific risk checks.
Four fundamentals lenses on the company itself: valuation, growth, returns & margins, and financial health, judged against the stock's sector. A separate read from the Market Setup above.
Fairly valued
₹1,000 invested here buys about ₹125 of annual profit. A cheaper stock would buy more.
Steady growth
Moderate returns
Strong balance sheet
Data as of 19 Jun 2026, 9:46 pm